Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Supporting COVID-19 policy response with large-scale mobility-based modeling

View ORCID ProfileSerina Chang, Mandy L. Wilson, Bryan Lewis, Zakaria Mehrab, Komal K. Dudakiya, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky, Madhav Marathe, Jure Leskovec
doi: https://doi.org/10.1101/2021.03.20.21254022
Serina Chang
1Department of Computer Science, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Serina Chang
Mandy L. Wilson
2Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan Lewis
2Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zakaria Mehrab
2Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Komal K. Dudakiya
3Persistent Systems, Pune, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Pierson
4Microsoft Research, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pang Wei Koh
1Department of Computer Science, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaline Gerardin
5Department of Preventive Medicine, Northwestern University, Chicago, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beth Redbird
6Department of Sociology, Northwestern University, Evanston, IL, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Grusky
7Department of Sociology, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhav Marathe
2Biocomplexity Institute & Initiative, University of Virginia, Charlottesville, VA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jure Leskovec
1Department of Computer Science, Stanford University, Stanford, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jure@cs.stanford.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Social distancing measures, such as restricting occupancy at venues, have been a primary intervention for controlling the spread of COVID-19. However, these mobility restrictions place a significant economic burden on individuals and businesses. To balance these competing demands, policymakers need analytical tools to assess the costs and benefits of different mobility reduction measures.In this paper, we present our work motivated by our interactions with the Virginia Department of Health on a decision-support tool that utilizes large-scale data and epidemiological modeling to quantify the impact of changes in mobility on infection rates. Our model captures the spread of COVID-19 by using a fine-grained, dynamic mobility network that encodes the hourly movements of people from neighborhoods to individual places, with over 3 billion hourly edges. By perturbing the mobility network, we can simulate a wide variety of reopening plans and forecast their impact in terms of new infections and the loss in visits per sector. To deploy this model in practice, we built a robust computational infrastructure to support running millions of model realizations, and we worked with policymakers to develop an intuitive dashboard interface that communicates our model’s predictions for thousands of potential policies, tailored to their jurisdiction. The resulting decision-support environment provides policymakers with much-needed analytical machinery to assess the tradeoffs between future infections and mobility restrictions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially supported by NSF BIG DATA Grant IIS-1633028, NSF Grant No. OAC-1916805, NSF Expeditions in Computing Grant CCF-1918656, CCF-1917819, NSF RAPID CNS-2028004, NSF RAPID OAC-2027541, NSF OAC-1835598 (CINES), NSF OAC-1934578 (HDR), NSF CCF-1918940 (Expeditions), NSF IIS-2030477 (RAPID), Stanford Data Science Initiative, Wu Tsai Neurosciences Institute, Chan Zuckerberg Biohub, United Health Group, US Centers for Disease Control and Prevention 75D30119C05935, University of Virginia Strategic Investment Fund award number SIF160, and Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA1-19-D-0007. S.C. was supported by an NSF Graduate Fellowship. P.W.K. was supported by the Facebook Fellowship Program. J.L. is a Chan Zuckerberg Biohub investigator.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

SafeGraph aggregates data from mobile applications that obtain opt-in consent from their users to collect anonymous location data. We obtained IRB exemption for SafeGraph data from the Northwestern University and University of Virginia IRB offices.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Mobile phone mobility data are freely available to researchers, non-profit organizations and governments through the SafeGraph COVID-19 Data Consortium. All other data come from publicly available sources; we provide links to these data below. The dataset from The New York Times consists of aggregated COVID-19-confirmed case and death counts collected by journalists from public news conferences and public data releases. We also use data from the National Center for Health Statistics (NCHS) to estimate national excess deaths. Our state-level mask-wearing data comes from the Institute for Health Metrics and Evaluation's (IHME) public dashboard. Additional data about US census block groups come from the US American Census Survey. Our code is also available online at https://github.com/snap-stanford/covid-mobility-tool.

https://www.safegraph.com/covid-19-data-consortium

https://github.com/nytimes/covid-19-data

https://www.cdc.gov/nchs/nvss/vsrr/covid19/excess_deaths.htm

https://covid19.healthdata.org/united-states-of-america

https://www.census.gov/programs-surveys/acs

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 26, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Supporting COVID-19 policy response with large-scale mobility-based modeling
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Supporting COVID-19 policy response with large-scale mobility-based modeling
Serina Chang, Mandy L. Wilson, Bryan Lewis, Zakaria Mehrab, Komal K. Dudakiya, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky, Madhav Marathe, Jure Leskovec
medRxiv 2021.03.20.21254022; doi: https://doi.org/10.1101/2021.03.20.21254022
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Supporting COVID-19 policy response with large-scale mobility-based modeling
Serina Chang, Mandy L. Wilson, Bryan Lewis, Zakaria Mehrab, Komal K. Dudakiya, Emma Pierson, Pang Wei Koh, Jaline Gerardin, Beth Redbird, David Grusky, Madhav Marathe, Jure Leskovec
medRxiv 2021.03.20.21254022; doi: https://doi.org/10.1101/2021.03.20.21254022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (423)
  • Anesthesia (97)
  • Cardiovascular Medicine (902)
  • Dentistry and Oral Medicine (172)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (408)
  • Epidemiology (8810)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1871)
  • Geriatric Medicine (179)
  • Health Economics (389)
  • Health Informatics (1294)
  • Health Policy (644)
  • Health Systems and Quality Improvement (495)
  • Hematology (207)
  • HIV/AIDS (397)
  • Infectious Diseases (except HIV/AIDS) (10593)
  • Intensive Care and Critical Care Medicine (565)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1770)
  • Nursing (105)
  • Nutrition (267)
  • Obstetrics and Gynecology (344)
  • Occupational and Environmental Health (461)
  • Oncology (968)
  • Ophthalmology (285)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (265)
  • Pediatrics (560)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (221)
  • Psychiatry and Clinical Psychology (1847)
  • Public and Global Health (3998)
  • Radiology and Imaging (657)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (538)
  • Rheumatology (216)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (167)
  • Surgery (199)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)